Cargando…
ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
Increasing evidence supports that ELL (eleven–nineteen lysine-rich leukaemia) is a key regulator of transcriptional elongation, but the physiological function of Ell in mammals remains elusive. Here we show that ELL functions as an E3 ubiquitin ligase and targets c-Myc for proteasomal degradation. I...
Autores principales: | Chen, Yu, Zhou, Chi, Ji, Wei, Mei, Zhichao, Hu, Bo, Zhang, Wei, Zhang, Dawei, Wang, Jing, Liu, Xing, Ouyang, Gang, Zhou, Jiangang, Xiao, Wuhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820845/ https://www.ncbi.nlm.nih.gov/pubmed/27009366 http://dx.doi.org/10.1038/ncomms11057 |
Ejemplares similares
-
Author Correction: ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
por: Chen, Yu, et al.
Publicado: (2023) -
Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy
por: Sun, Xiao-Xin, et al.
Publicado: (2021) -
Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins
por: Sasada, Manabu, et al.
Publicado: (2019) -
Tet1 facilitates hypoxia tolerance by stabilizing the HIF-α proteins independent of its methylcytosine dioxygenase activity
por: Wang, Jing, et al.
Publicado: (2017) -
Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors
por: Tran, Huy Minh, et al.
Publicado: (2020)